CTOs on the Move

State of Minnesota

www.education.mn.gov

 
State of Minnesota is a Minnesota-based government organization that oversees and manages economic development and civilian welfare.
  • Number of Employees: 10K-50K
  • Annual Revenue: $500M-1 Billion
  • www.education.mn.gov
  • 75 Rev Dr Martin Luther King Junior Boulevard.
    Saint Paul, MN USA
  • Phone: 651.259.3015

Executives

Name Title Contact Details

Similar Companies

Life Settlement Leads

Life Settlement Leads is a Parsippany, NJ-based company in the Business Services sector.

Watseka Interstate

Watseka Interstate, LLC is a Watseka, IL-based company in the Business Services sector.

LinguaSys

LinguaSys is a Next Generation language translation software company dedicated to creating the best experience for enterprises that need a secure and highly customized solution for gist translations of collaboration content. LinguaSys was formed to fill a void in the MT industry, which is to cater to enterprise customers who are currently underserved in quality, language availability, and customization capability by the current enterprise MT players. With over 30 years of MT experience and three different MT systems between the founders, we offer a breadth and knowledge of the MT industry and the proper use of MT that cannot be matched. We offer creation of new MT languages, customized lexical services, and our Next Generation Carabao MT technology, along with the TransGen UI for ease of use behind the firewall for the entire enterprise.

Blue Portal

Blue Portal is a Albuquerque, NM-based company in the Business Services sector.

Monopar Therapeutics Inc.

Monopar Therapeutics is a clinical­-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. Monopars pipeline consists of camsirubicin (Phase 1b) for the treatment of advanced soft tissue sarcoma; MNPR­101, a late-­stage preclinical antibody for radiopharmaceutical use in advanced cancers; and MNPR­202, an early-stage camsirubicin analog for various cancers.